Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07328178

Analysis of the Role of IgE Proteoforms in Health and Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of anaphylaxis, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), and patients undergoing desensitization for venom or medication allergy.

Conditions

Interventions

TypeNameDescription
OTHERBlood sample collectionBlood sample collection

Timeline

Start date
2025-01-01
Primary completion
2029-01-01
Completion
2029-01-01
First posted
2026-01-09
Last updated
2026-01-09

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT07328178. Inclusion in this directory is not an endorsement.